データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions
Press Release: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
Achilles Therapeutics 3Q Loss/Shr 48c >ACHL
Press Release: Achilles Therapeutics Reports Third Quarter 2024 Financial Results